Boehringer Ingelheim Ups The Ante In Treating Lung Disorders
Tunde Otulana, M.D., heads Boehringer Ingelheim’s clinical development and medical affairs group. He is a former FDA reviewer who studied, learned, and finally got the chance to apply his knowledge of clinical trials when he stepped over into industry in 1997. As a pulmonologist who previously worked for about seven years in the FDA’s pulmonary division, Otulana subsequently led related R&D efforts at several companies before coming to BI in 2011. He now plays a key role in the U.S. in preserving the company’s position as a pioneer and leader in respiratory therapy, mainly in chronic obstructive pulmo...
Source: Pharmaceutical Online News - July 31, 2014 Category: Pharmaceuticals Source Type: news
Respiratory therapy, medical students to volunteer in Nicaragua
Mid-July excursion will take students to Central American nation to aid health care providers in rural villages with health assessments, other tasks. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - June 24, 2014 Category: Universities & Medical Training Source Type: news
Transcript posted for February 20, 2014 Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee Meeting
(Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - March 19, 2014 Category: Medical Equipment Source Type: news
24 Hour Summary posted for February 20, 2014 Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee Meeting
(Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 24, 2014 Category: Medical Equipment Source Type: news
Report: FDA panel recommends Inspire Medical's sleep apnea implant
The FDA's Anesthesiology & Respiratory Therapy Devices Panel unanimously recommends Inspire Medical's Inspire II Upper Airway Stimulator for U.S. approval.
An expert panel of FDA advisors voted today to recommend approval for Inspire Medical's sleep apnea implant, the Inspire II Upper Airway Stimulator, according to The Gray Sheet.
Food & Drug Administration (FDA), Inspire Medical Systems Inc.News Well, Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Pre-Market Approval (PMA), Sleep Monitoring/Sleep Apnearead more (Source: Mass Device)
Source: Mass Device - February 21, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
FDA reviews adverse events, durability of Inspire Medical's sleep apnea implant
Inspire Medical's Inspire II Upper Airway Stimulator heads to the FDA tomorrow, when an expert panel will consider admitting the device to the U.S. market.
Minnesota-based Inspire Medical Systems has a date with the FDA tomorrow, when the agency's expert Anesthesiology & Respiratory Therapy Devices Panel will review data and make a recommendation on the Inspire II Upper Airway Stimulator.
Food & Drug Administration (FDA), Inspire Medical Systems Inc.News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Minnesota, Neuromodulation/Neurostimulation, Pre-Market Approval (PMA), Sle...
Source: Mass Device - February 19, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
Apex Embarks on Counter Actions Against ResMed in Europe
DUSSELDORF, Germany, Feb. 19, 2014 -- (Healthcare Sales & Marketing Network) -- Apex Medical Corporation (APEX, TWSE: 4106) a leading player in the Respiratory Therapy and Pressure Area Care sectors issues the following press release:
Apex announced at... Devices, LitigationApex Medical, ResMed, continuous positive airway pressure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 19, 2014 Category: Pharmaceuticals Source Type: news
Materials posted for February 20, 2014 Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee Meeting
(Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 18, 2014 Category: Medical Equipment Source Type: news
CEO Insights: Changing the standard of care for acute respiratory therapy
ALung chairman & CEO Peter DeComo talks about advances in respiratory therapy and his company's Hemolung respiratory system.
By Peter M. DeComo, chairman and CEO of ALung Technologies, Inc.
News Well, Blog, Respiratoryread more (Source: Mass Device)
Source: Mass Device - January 22, 2014 Category: Medical Equipment Authors: MassDevice Tags: ALung Technologies Inc. Contributed Blogs Source Type: news
Federal Register: Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - January 8, 2014 Category: Medical Equipment Source Type: news
Meeting Notice: February 20, 2014: Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee Meeting
(Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - January 8, 2014 Category: Medical Equipment Source Type: news
Wearable Medical Devices Market Is Expected To Reach USD 5.8 Billion Globally In 2019: Transparency Market Research
According to a new market report published by Transparency Market Research"Wearable Medical Devices Market (Heart Rate Monitors, Activity Monitors, ECG, Pulse Oximeters, EEG, EMG, Glucose/Insulin Management, Pain Management, Wearable Respiratory Therapy)-Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019,"the global market for wearable medical devices was valued atUSD 2.0 billionin 2012 and is expected to reach a value ofUSD 5.8 billionin 2019, growing at a CAGR of 16.4% from 2013 to 2019. (Source: Medical Design Online News)
Source: Medical Design Online News - December 12, 2013 Category: Medical Equipment Source Type: news
Prague-based Unimedis Acquired by ResMed
Deal will Increase Accessibility of Leading Sleep and Respiratory Therapies in Czech Republic
SAN DIEGO and PRAGUE, Dec. 2, 2013 -- (Healthcare Sales & Marketing Network) -- Prague-based Unimedis, a distributor of equipment for the treatment of sleep d... Devices, Distribution, Mergers & AcquisitionsResMed, Unimedis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 2, 2013 Category: Pharmaceuticals Source Type: news
Respiratory Therapy May Lower Death Risk for Some Sleep Apnea Patients
Title: Respiratory Therapy May Lower Death Risk for Some Sleep Apnea PatientsCategory: Health NewsCreated: 8/14/2013 4:35:00 PMLast Editorial Review: 8/15/2013 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - August 15, 2013 Category: Sleep Medicine Source Type: news
Respiratory Therapy May Lower Death Risk for Some Sleep Apnea Patients
Study looked at those who also have the respiratory condition COPD (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 14, 2013 Category: Respiratory Medicine Authors: webmaster at doctorslounge.com Tags: Family Medicine, Neurology, Pulmonology, News, Source Type: news
